HighTower Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
5,220
-279
-5% -$69.4K ﹤0.01% 2007
2025
Q4
$1.51M Sell
5,499
-1,070
-16% -$293K ﹤0.01% 1838
2025
Q3
$1.72M Sell
6,569
-2,249
-26% -$547K ﹤0.01% 1721
2025
Q2
$1.93M Sell
8,818
-1,369
-13% -$293K ﹤0.01% 1586
2025
Q1
$2.28M Sell
10,187
-163
-2% -$44.9K ﹤0.01% 1455
2024
Q4
$3.39M Buy
10,350
+1,812
+21% +$570K ﹤0.01% 1227
2024
Q3
$2.58M Sell
8,538
-963
-10% -$295K ﹤0.01% 1361
2024
Q2
$3.13M Buy
9,501
+282
+3% +$99.7K ﹤0.01% 1214
2024
Q1
$3.65M Sell
9,219
-145
-2% -$53.6K 0.01% 1109
2023
Q4
$3.29M Sell
9,364
-1,774
-16% -$628K 0.01% 1169
2023
Q3
$4.21M Sell
11,138
-436
-4% -$169K 0.01% 1003
2023
Q2
$4.45M Buy
11,574
+59
+0.5% +$21.1K 0.01% 963
2023
Q1
$3.98M Buy
11,515
+972
+9% +$284K 0.01% 956
2022
Q4
$2.48M Buy
10,543
+1,057
+11% +$250K 0.01% 1173
2022
Q3
$2.31M Sell
9,486
-48
-0.5% -$14.6K 0.01% 1156
2022
Q2
$2.89M Sell
9,534
-1,218
-11% -$396K 0.01% 1059
2022
Q1
$4.42M Sell
10,752
-4,525
-30% -$1.77M 0.01% 954
2021
Q4
$7.17M Buy
15,277
+5,453
+56% +$2.35M 0.02% 734
2021
Q3
$4.17M Buy
9,824
+1,589
+19% +$670K 0.01% 908
2021
Q2
$2.96M Buy
8,235
+966
+13% +$319K 0.01% 1022
2021
Q1
$2.05M Buy
+7,269
New +$2.08M 0.01% 1117
2020
Q4
Sell
-7,309
Closed -$2M 2944
2020
Q3
$2M Buy
7,309
+2,541
+53% +$672K 0.01% 868
2020
Q2
$1.07M Buy
4,768
+454
+11% +$89.2K 0.01% 1079
2020
Q1
$658K Buy
4,314
+210
+5% +$32.3K ﹤0.01% 1204
2019
Q4
$622K Sell
4,104
-1,054
-20% -$153K ﹤0.01% 1353
2019
Q3
$729K Buy
5,158
+53
+1% +$7.3K ﹤0.01% 1337
2019
Q2
$642K Buy
5,105
+372
+8% +$43.9K ﹤0.01% 1396
2019
Q1
$515K Buy
4,733
+444
+10% +$46.2K ﹤0.01% 1447
2018
Q4
$423K Buy
4,289
+1,489
+53% +$162K ﹤0.01% 1440
2018
Q3
$343K Buy
+2,800
New +$314K ﹤0.01% 1662

Other funds holding WST